Identification of Novel HLA Alleles: HLA-DRB1*13:358 and HLA-DQB1*05:333 in Brazilian Individuals.
Identification of the novel HLA alleles HLA-DRB1*13:358 and HLA-DQB1*05:333 in Brazilian individuals.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Identification of the novel HLA alleles HLA-DRB1*13:358 and HLA-DQB1*05:333 in Brazilian individuals.
The novel alleles HLA-B*51:429 and HLA-DRB*111:352 and the extended allele HLA-DQB1*06:161 were identified during routine HLA typing.
Identification of eight novel HLA-DRB1 and HLA-DQB1 alleles by next-generation sequencing.
HLA typing of 9126 haematopoietic stem cell donors living in the Asian and European parts of Russia and identifying themselves as Russians was performed using NGS technology in 2-field resolution at the HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci. The study of donors in the Asian part of Russia disclosed 77 alleles at the HLA-A locus, 111 at the HLA-B locus, 58 at the HLA-C locus, 54 at the HLA-DRB1 locus, and 26 at the HLA-DQB1 locus. Donors of the European part of Russia are characterised by the following allelic diversity: 87 alleles at the HLA-A locus, 136 at the HLA-B locus, 72 at the HLA-C locus, 67 at the HLA-DRB1 locus, and 37 at the HLA-DQB1 locus. The most common five-locus haplotype in both populations is HLA-A*01:01 ~ HLA-C*07:01 ~ HLA-B*08:01 ~ HLA-DRB1*03:01 ~ HLA-DQB1*02:01. Throughout the study, 26 new alleles were revealed.
OBJECTIVE: Anticitrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) can be promiscuous, with cross-reactive binding to many antigens containing short motifs, or private with little cross-reactivity. Also, ACPA reactivity patterns differ among patients with RA, including for motif-containing epitopes in important self-antigens like collagen and IgG (bound by RA-associated rheumatoid factors [RFs]), with limited understanding of the underlying mechanism. The objective of this study was to determine if HLA alleles associate with ACPA reactivity patterns. METHODS: For 100 ACPA+RF+ participants with RA, serum IgG binding was quantified by enzyme-linked immunosorbent assay to 10 citrulline-containing peptides derived from Type II collagen and IgG1 (nine with motifs), and HLA loci were genotyped. Also, antibody and serum multireactivity were evaluated. HLA alleles present differentially in RA participants with high versus low IgG binding to specific peptides, as well as with multireactivity versus limited reactivity were identified by Fisher's exact test. RESULTS: Serum IgG multireactivity for citrulline-glycine motif-containing collagen peptides was high, at least partially due to promiscuous antibodies. HLA-DQA1*01:02 was present in more participants with anticitrullinated collagen antibodies and multireactive sera. In contrast, serum multireactivity was low for IgG1-derived peptides due at least in part to more private antibodies. Shared epitope-containing HLA-DRB1*04:01 was present more frequently in participants with RA-associated RFs irrespective of the citrulline-serine motif and less frequently in participants with anticitrullinated collagen antibodies. Several HLA alleles associated with specific antibody reactivities. CONCLUSION: Different HLA alleles may contribute to the different reactivity patterns of promiscuous anticitrullinated collagen antibodies and more private RA-associated RFs.
The complete genomic sequence of HLA-DRB1*13:97:01 was determined using a PacBio sequencing approach conducted in China.
Genomic sequence of HLA-B*40:06:01:20 and HLA-DRB1*09:61N alleles detected in a Spanish individual.
HLA-DRB1*13:369 differs from HLA-DRB1*13:03:01:01 by one nucleotide substitution in codon 76 in exon 2.
The complete genomic sequence of HLA-DRB1*04:90 was determined using a PacBio sequencing approach conducted in China.
The HLA-DRB1*12:110 allele differs from the HLA-DRB1*12:01:01:05 allele by a single nucleotide at codon 179 in exon 3.
HLA-DRB1*12:113 differs from HLA-DRB1*12:01:01:14 at codon 95 (GTC>ATC) and codon 191 (CGG>TGG).
The novel HLA-DRB1*13:368 allele differs from HLA-DRB1*13:01:01:01 by one nucleotide substitution G → T in exon 3.
Five HLA-DRB1 alleles were confirmed and the sequences extended in our laboratory.
Three novel HLA-DRB1 alleles were identified during routine next generation sequencing.
HLA influence the immune response, shaping genetic susceptibility or resistance to tuberculosis (TB). This study aimed to investigate the associations of host genetics and comorbidities with TB infection in Taiwanese populations. This retrospective case-control study utilised data from the Taiwan Precision Medicine Initiative. TB cases and non-TB controls were compared using genome-wide association studies (GWAS), HLA allele typing, and genotype data. Multivariate logistic regression identified independent predictors of TB and interactions between risk factors. A total of 390 TB cases and 3,909 controls were analysed. Risk factors for TB included bronchiectasis (OR = 2.76; 95% CI 1.54-4.44; p < 0.001), diabetes mellitus (OR = 1.30; 95% CI 1.00-1.68; p = 0.050), malignancy (OR = 1.46; 95% CI 1.15-1.85; p = 0.002), smoking (OR = 1.42; 95% CI 1.08-1.88; p = 0.012), and steroid use (OR = 1.66; 95% CI 1.29-2.13; p < 0.001). HLA-DRB1*16:02 was associated with a higher frequency in the TB group (OR = 1.47; 95% CI 1.04-2.09; p = 0.030). Interaction analysis showed HLA-DRB1*16:02 increased TB risk in non-smokers (OR = 1.58; 95% CI 1.02-2.46; p = 0.042), but not in smokers. HLA-DRB1*16:02 was associated with a higher risk for TB. While carriers of HLA-DRB1*16:02 did not exhibit an increased risk of TB among smokers, we demonstrated a heightened risk among non-smokers.
The novel allele HLA-DRB1*13:371 differs from HLA-DRB1*13:02:01:01 by one nucleotide substitution in codon 127 in exon 3.
HLA-DRB1*11:351 differs from HLA-DRB1*11:04:01:01 by one nucleotide substitution in codon 229 in exon 5.
HLA-DRB1*09:01:18 differs from HLA-DRB1*09:01:02:01 by one nucleotide substitution in codon 44 in exon 2.